Are Cosmetic Endocrine-Disruptor Checks Sufficient? EU Commission Issues Long-Awaited Position
This article was originally published in The Rose Sheet
Executive Summary
Industry no doubt welcomes the Commission’s long-overdue review of the European Cosmetics Regulation as it pertains to chemicals with endocrine-disrupting properties. The report concludes that the existing regulatory framework is adequate to evaluate and manage suspected endocrine disruptors, while putting stakeholders on notice that a number of prioritized ingredients will be up for review in 2019.
You may also be interested in...
EU Scientific Committee Reviewing Three UV Filters Against Endocrine-Disrupting Concerns
The European Commission issued requests on 4 February for updated opinions from the Scientific Committee on Consumer Safety on octocrylene, homosalate and benzophenone-3, in light of concerns that led to their listing in 2019 as “higher priority” substances used in cosmetics with endocrine-disrupting potential.
Endocrine Disruptors, The European Green Deal And The Politicization Of EU Chemical Programs
John Chave, director-general at Cosmetics Europe, says the European Commission’s plan for targeted assessment of 28 potential endocrine-disruptors in cosmetics – despite its conclusion in late 2018 that the current cosmetics regulatory framework adequately addresses endocrine-disruptor concerns – is symptomatic of a broad trend taking hold in Europe.
Danish Retail Group Blacklists Cosmetics With PFAS; Australian Animal-Testing Ban; More Cosmetics News
Cosmetics containing fluorinated compounds are no longer welcome in Coop Denmark’s 1,050 stores or its e-commerce platform. Meanwhile, consumer group BEUC proposes changes to the European Cosmetics Regulation to address endocrine-disrupting chemicals, and Australia passes legislation to bar new, cosmetics-only chemicals from market if their safety substantiation relies on animal testing.